Open-angle Glaucoma
📧 Sign up to get email alerts when something new happens for Open-angle Glaucoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-10Clinical Trial Update: MIMS® Retrospective Chart Review
An update on a retrospective chart review study of MIMS for open-angle glaucoma; the study has not yet begun recruiting.
-
CLINICAL_TRIALS trial_result · 2024-12-20Clinical Trial Update: Intraoperative 5-fluorouracil Augmentation of Trabeculectomy [Phase 3]
Phase 3 clinical trial update evaluating intraoperative 5-fluorouracil augmentation of trabeculectomy in glaucoma. The study status is compl…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Safety and Effectiveness of VISULAS Green Selective Laser Trabeculoplasty (SLT) [NA]
Completed clinical trial evaluating the safety and effectiveness of VISULAS Green Selective Laser Trabeculoplasty for primary open-angle gla…
-
CLINICAL_TRIALS trial_result · 2024-12-19Clinical Trial Update: Efficacy and Safety of Trabecular Meshwork Microstent Drainage System ( MicroCOGO ) [NA]
Clinical trial update on the efficacy and safety of the MicroCOGO trabecular meshwork drainage system for open-angle glaucoma (with cataract…
-
EMA withdrawal · 2024-12-17EMA Application withdrawn: Durysta (bimatoprost) — AbbVie Deutschland GmbH & Co. KG
The EMA has withdrawn the marketing authorization application for Durysta (bimatoprost) submitted by AbbVie Deutschland GmbH & Co. KG for op…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-12-12Clinical Trial Update: Safety and Performance Study of the ARGOS-IO (Intraocular) System in Patients With Primary Open Angle Glaucoma (POAG) [NA]
Completed safety and performance evaluation of the ARGOS-IO intraocular system for primary open-angle glaucoma; trial results have been post…
-
CLINICAL_TRIALS research · 2024-12-11Clinical Trial Update: Evaluation of Phacogoniotomy in Medically-controlled POAG [NA]
Clinical trial evaluating phacogoniotomy in patients with medically controlled primary open-angle glaucoma and cataract; recruitment is ongo…
-
CLINICAL_TRIALS other · 2024-12-03Clinical Trial Update: Uddevalla Skövde Transscleral Micropulse Study
Enrollment by invitation is noted for the Uddevalla Skövde Transscleral Micropulse Study investigating treatment options for primary open-an…
-
FDA approval · 2024-11-26FDA Approved: LATANOPROST — Original Application (Sagent Pharmaceuticals)
FDA approved the original application for latanoprost from Sagent Pharmaceuticals (a generic).
-
EMA approval · 2024-11-18EMA Authorised: Lumigan (bimatoprost) — AbbVie Deutschland GmbH & Co. KG
The EMA authorised Lumigan (bimatoprost) for open-angle glaucoma and ocular hypertension, with AbbVie Deutschland GmbH & Co. KG as the marke…
-
CLINICAL_TRIALS research · 2024-11-18Clinical Trial Update: Effects of Primary Open-angle Glaucoma on Visual-motor Coordination
A clinical trial evaluating whether primary open-angle glaucoma affects visual-motor coordination; currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-11-18Clinical Trial Update: GlaucoT Glaucoma Treatment Glasses in the Treatment of Primary Open-Angle Glaucoma [NA]
A completed clinical trial evaluating GlaucoT Glaucoma Treatment Glasses for primary open-angle glaucoma has been updated.
-
CLINICAL_TRIALS research · 2024-11-15Clinical Trial Update: Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt
A clinical trial update notes ongoing recruitment for evaluating the long-term safety and effectiveness of a modified suprachoroidal silicon…
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma [NA]
A clinical trial update compares the STREAMLINE Surgical System with the iStent Inject W in open-angle glaucoma, with the study currently li…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Safety [Phase 4]
Phase 4 trial comparing preservative-free dorzolamide + timolol with preserved dorzolamide + timolol in open-angle glaucoma and ocular hyper…
-
CLINICAL_TRIALS trial_result · 2024-11-01Clinical Trial Update: Combined Phacoemulsification With iStent Inject W Versus Hydrus for Mild to Moderate Open Angle Glaucoma [NA]
A clinical trial comparing phacoemulsification with iStent Inject W versus Hydrus for mild to moderate open-angle glaucoma has been terminat…
-
CLINICAL_TRIALS trial_result · 2024-10-29Clinical Trial Update: A Phase 1b Study of ONL1204 Ophthalmic Solution in Patients with Progressing Open Angle Glaucoma [Phase 1]
Phase 1b study evaluating ONL1204 ophthalmic solution for progression of open-angle glaucoma has completed enrollment/status.
-
FDA approval · 2024-10-10FDA Approved: DURYSTA — Supplemental Application (Allergan, Inc.)
The FDA approved a supplemental application for Durysta (bimatoprost) from Allergan, Inc., to modify the product’s labeling and/or approved …
-
FDA approval · 2024-10-10FDA Approved: TIMOLOL HEMIHYDRATE — Original Application (Somerset Therapeutics, LLC)
FDA approved the original application for Timolol hemihydrate, a generic ophthalmic solution, from Somerset Therapeutics, LLC.
-
FDA approval · 2024-10-09FDA Approved: XELPROS — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for XELPROS (latanoprost) submitted by Sun Pharmaceutical Industries.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: Trabecular Microbypass IStent in Patients with Glaucoma [NA]
Clinical trial update noting the completion of a study evaluating trabecular microbypass stents (iStent Inject W) in glaucoma patients, incl…
-
CLINICAL_TRIALS trial_result · 2024-10-01Clinical Trial Update: CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension [Phase 1]
This Phase 1 trial evaluated the safety and preliminary efficacy of OTX-TIC in participants with open-angle glaucoma or ocular hypertension,…
-
CLINICAL_TRIALS research · 2024-09-26Clinical Trial Update: Inferonasal MIMS® Procedure: Long-Term Follow-Up Extension Study
Clinical trial update for the Inferonasal MIMS Procedure describes a long-term follow-up extension study in open-angle glaucoma, with recrui…
-
FDA approval · 2024-09-18FDA Approved: RHOPRESSA — Supplemental Application (Alcon Laboratories, Inc.)
FDA approves a supplemental application for RHOPRESSA (netarsudil) filed by Alcon Laboratories, Inc.
-
FDA approval · 2024-09-16FDA Approved: IYUZEH — Supplemental Application (Thea Pharma Inc.)
FDA approves a supplemental application for IYUZEH (latanoprost ophthalmic solution 0.005%). This approval expands the product's labeling re…